rs370899710
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_147196.3(TMIE):c.366T>G(p.Asp122Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000094 in 1,552,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_147196.3 missense
Scores
Clinical Significance
Conservation
Publications
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive nonsyndromic hearing loss 6Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMIE | NM_147196.3 | c.366T>G | p.Asp122Glu | missense_variant | Exon 4 of 4 | ENST00000643606.3 | NP_671729.2 | |
TMIE | NM_001370524.1 | c.207T>G | p.Asp69Glu | missense_variant | Exon 4 of 4 | NP_001357453.1 | ||
TMIE | NM_001370525.1 | c.207T>G | p.Asp69Glu | missense_variant | Exon 5 of 5 | NP_001357454.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMIE | ENST00000643606.3 | c.366T>G | p.Asp122Glu | missense_variant | Exon 4 of 4 | NM_147196.3 | ENSP00000494576.2 | |||
TMIE | ENST00000644830.1 | c.207T>G | p.Asp69Glu | missense_variant | Exon 4 of 4 | ENSP00000495111.1 | ||||
TMIE | ENST00000651652.1 | c.*288T>G | 3_prime_UTR_variant | Exon 2 of 2 | ENSP00000498953.1 |
Frequencies
GnomAD3 genomes AF: 0.0000467 AC: 7AN: 149950Hom.: 0 Cov.: 26 show subpopulations
GnomAD2 exomes AF: 0.000124 AC: 18AN: 145554 AF XY: 0.000128 show subpopulations
GnomAD4 exome AF: 0.0000991 AC: 139AN: 1402592Hom.: 0 Cov.: 43 AF XY: 0.000107 AC XY: 75AN XY: 698904 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000467 AC: 7AN: 149950Hom.: 0 Cov.: 26 AF XY: 0.0000274 AC XY: 2AN XY: 73004 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis indicates that this missense variant does not alter protein structure/function; Identified in a patient with autism spectrum disorder and reported to be de novo in published literature (PMID: 28714951); This variant is associated with the following publications: (PMID: 28714951) -
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 47960). This variant has not been reported in the literature in individuals affected with TMIE-related conditions. This variant is present in population databases (rs370899710, ExAC 0.01%). This sequence change replaces aspartic acid with glutamic acid at codon 122 of the TMIE protein (p.Asp122Glu). The aspartic acid residue is moderately conserved and there is a small physicochemical difference between aspartic acid and glutamic acid. -
Autosomal recessive nonsyndromic hearing loss 6 Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
Asp122Glu in exon 4 of TMIE: This variant is not expected to have clinical signi ficance because this amino acid is not evolutionarily conserved with several mam mals, including rabbit, cat, and cow, carrying a glutamic acid (Glu) at this pos ition. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at